Duopharma Biotech Berhad, the distributor of the Sinopharm vaccine, was one of the winners of the pandemic. But with a price cap set by the government, how will that impact the company? Leonard Ariff Bin Abdul Shatar, Group Managing Director, Duopharma Biotech Bhd answers those questions and their strategy for growth.

Produced by: Moh Heng Ying

Presented by: Wong Shou Ning

This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories:  social issues,  business analysis,  trends and forecasts,  diseases and conditions,  healthy living,  health policy,  medical innovation and technology

Tags:  duopharma,  sinopharm,  duopharma biotech,  vaccines,  pharmaceuticals,